CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS

被引：21
|
作者：
Martínez-Yélamos, A
Rovira, A
Sánchez-Valle, R
Martínez-Yélamos, S
Tintoré, M
Blanco, Y
Graus, F
Montalban, X
Arbizu, T
Saiz, A
机构：
[1] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Serv Neurol, Barcelona 08036, Spain
[2] Ciutat Sanitaria Univ Bellvitge, Serv Neurol, Lhospitalet De Llobregat, Spain
[3] Hosp Univ Vall Hebron, Clin Neuroimmunol Unit, Barcelona, Spain
来源：
JOURNAL OF NEUROLOGY | 2004年 / 251卷 / 10期
关键词：
D O I：
10.1007/s00415-004-0524-y
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1278 / 1279
页数：2
相关论文
共 50 条
  • [41] Treatment with glatiramer acetate reduces MRI activity in patients with clinically isolated syndrome suggestive of multiple sclerosis
    Filippi, M.
    Comi, G.
    JOURNAL OF NEUROLOGY, 2008, 255 : 179 - 180
  • [42] CSF neurofilaments and N-acetylaspartate in relation to MRI-metrics at 3T in clinically isolated syndromes suggestive of multiple sclerosis
    Khalil, M.
    Enzinger, C.
    Langkammer, C.
    Ropele, S.
    Mader, A.
    Vane, M.
    Trentini, A.
    Wallner-Blazek, M.
    Archelos, J. -J.
    Blankenstein, M. A.
    Fuchs, S.
    Fazekas, F.
    Teunissen, C. E.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S266 - S267
  • [43] 88% of Recent Onset Polyarthritis Patients Are Positive for 14-3-3η Markers and 14-3-3η Auto-Antibodies Inform a Favourable Prognosis
    Boire, Gilles
    Carrier, Nathalie
    de Brum-Fernandes, Artur Jose
    Liang, Patrick
    Masetto, Ariel
    Gui, Yuan
    Murphy, Mairead
    Maksymowych, W. P.
    Marotta, Anthony
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S151 - S152
  • [44] 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein
    Green, AJE
    Ramljak, S
    Müller, WEG
    Knight, RSG
    Schröder, HC
    NEUROSCIENCE LETTERS, 2002, 324 (01) : 57 - 60
  • [45] A national surveillance study of Creutzfeldt-Jakob disease in Taiwan and the role of CSF 14-3-3 protein assay in its diagnostic criteria
    Chen, SS
    Lai, SL
    Kao, YF
    Hsu, SP
    Twu, SJ
    NEUROLOGY, 2002, 58 (07) : A443 - A443
  • [46] 14-3-3 Protein in CSF Reflects SIV-Mediated Pre-Synaptic Damage
    Helke, Kristi L.
    Queen, Suzanne E.
    Mankowski, Joseph L.
    CURRENT HIV RESEARCH, 2013, 11 (04) : 281 - 287
  • [47] A novel binding assay for detection of 14-3-3 protein in cerebrospinal fluid from Creutzfeldt-Jakob patients
    Leuck, J
    Peoc'h, K
    Laplanche, JL
    Grabar, E
    Müller, WEG
    Schröder, HC
    CELLULAR AND MOLECULAR BIOLOGY, 2000, 46 (07) : 1291 - 1296
  • [48] CSF 14-3-3 IS MORE SENSITIVE THAN CSF TAU PROTEIN FOR THE DIAGNOSIS OF SPORADIC CREUTZFELDT-JAKOB DISEASE
    Green, A. J. E.
    Chohan, G. K.
    Pennington, C. M.
    McKenzie, J. M.
    Will, R. G.
    Knight, R. S. G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (01): : 103 - 103
  • [49] Analysis of EEG and CSF 14-3-3 protein as aids to the diagnosis of Creutzfeldt-Jakob disease
    Zerr, I
    Pocchiari, M
    Collins, S
    Brandel, JP
    Cuesta, JD
    Knight, RSG
    Bernheimer, H
    Cardone, F
    Delasnerie-Lauprêtre, N
    Corrales, NC
    Ladogana, A
    Bodemer, M
    Fletcher, A
    Awan, T
    Bremón, AR
    Budka, H
    Laplanche, JL
    Will, RG
    Poser, S
    NEUROLOGY, 2000, 55 (06) : 811 - 815
  • [50] 14-3-3 sigma expression and prognostic value in patients with epithelial ovarian carcinoma
    Mhawech-Fauceglia, P.
    Herrmann, F. R.
    Andrews, C.
    Lele, S.
    Odunsi, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345